Glossary

Home  /  Glossary

 

Abbreviation Description
AC Activity centre
AL Activity leader
CA Collaborative Assessment
CDDF The Cancer Drug Development Forum
CEESTAHC Central and Eastern European Society of Technology Assessment in Health Care
CG Companion Guide
CHAFEA Consumers, Health, Agriculture and Food Executive Agency
CHMP Committee on Human Medicinal Products
CIRS The Centre for Innovation in Regulatory Science
COCIR European Coordination Committee of the Radiological, Electromedical and Healthcare IT Industry
CoLP Co-Lead Partner
CSR Corporate Social Responsibility
D Deliverable
DB Database
DG SANTE Director General for Health & Food Safety (European institution)
DIA Driving Insights to Action
DOICU Declaration of Interest and Confidentiality form
EACPT European Association for Clinical Pharmacology and Therapeutics
EB Executive Board
EC European Commission
ECAS European Commission’s main authentication service
ECPC European Cancer Patient Coalition
ED Early Dialogue
ED Secretariat Early Dialogue secretariat
EDC Early Diaologue Committee
EDFMS Early Diaologue Financing Mechanism Secretariat
EDWP Early Dialogues Working Party
EFPIA European Federation of Pharmaceutical Industries and Associations
EFSPI European Federation of Statisticians in the Pharmaceutical Industry
EMA European Medicines Agency
ENCePP European Network of Centres for Pharmacoepidemiology and Pharmacovigilance
EPA European Public Assessment report
EUNETHTA ID EUnetHTA Identification
EURODIS Non-profit alliance focusing on rare diseases in Europe
EVIDENT db Evidence database on New Technologies
EXAG Expert Advisory Group
F2F Face to Face
GA Grant Agreement
G-BA Gemeinsamer Bundesasschuss
GMDS German Society for Medical Informatics, Biometry and Epidemiology
HAS French National Authority for Health
HTA Health Technology Assessment
HTAB Health Technology Assessment Body
HTAi Health Technology Assessment international (htai.org)
IMDRF International Medical Device Regulators Forum
IMI Innovative Medicines Initiative
INAHTA International Network of Agencies for Health Technology Assessment (inahta.org)
ISPOR International Society For Pharmacoeconomics and Outcomes Research
IQWiG Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
JA Joint Assessment
JA1 Joint Action 1
JA2 Joint Action 2
JA3 Joint Action 3
LDAP Lightweight Directory Access Protocol
LP Lead Partner
M Month
MD Medical Devices
MD Major Deliverable
MDCG Medical Device Coordination Group
MEDEV Medicine Evaluation Committee
MedTech Medical technologies
MoH Ministry of Health
MPNCEE Melanoma Patient Network Central and Eastern Europe
MS Milestone
NITAG National Immunization Technical Advisory Groups
OT Other technologies
PARENT Cross Border Patient Rgistries Initiative
PC Parallel Consultation
PC Consolidated Parallel Consultation
PCI Individual Parallel Consultation
PL Project leader
PLEG Post Launch Evidence Generation
PMT Project Management Tool
POP Planned and Ongoing Project Database
PRIME Priority Medicines
PSA Parallel Scientific Advice Programme
PSI Promoting Statistical Insight
PT  Pharmaceutical Technologies
QM Quality Management
REA Relative Effectiveness Assessment
REDETSA Red de Evaluación de Tecnologías en Salud de las Américas
RWD Real-world data
SABA Web conferencing platform
SEED Shaping European Early Dialogues for health technologies
SOP Standard Operating Procedure
TC Teleconferencing
TG Task group
TISP Working group for Topic Identification, Selection and Prioritisation
UU-WHO University of Utrecht
WCD Wearable cardioverter defibrillator
WHO World Health Organisation
WP Work package
ZIN Zorginstituut Nederland